Dose–response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy
- 26 November 2001
- journal article
- clinical trial
- Published by Elsevier in Epilepsy Research
- Vol. 48 (1-2) , 77-89
- https://doi.org/10.1016/s0920-1211(01)00323-0
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugsPharmacological Research, 2000
- Efficacy and Tolerability of Levetiracetam 3000 mg/d in Patients with Refractory Partial Seizures: A Multicenter, Double‐Blind, Responder‐Selected Study Evaluating MonotherapyEpilepsia, 2000
- Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial SeizuresEpilepsia, 2000
- Levetiracetam for partial seizuresNeurology, 2000
- Pharmacokinetic profile of levetiracetamPharmacology & Therapeutics, 2000
- Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsyPublished by Elsevier ,1998
- Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsyEpilepsy Research, 1995
- Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and ratsEuropean Journal of Pharmacology, 1993
- Design and Analysis of Cross-Over TrialsPublished by Taylor & Francis ,1989
- Proposal for Classification of Epilepsies and Epileptic SyndromesEpilepsia, 1985